DSCAM and breast carcinoma: Third, the cellular experiments indicated that silencing of DSCAM-AS1 or overexpression of miR-130a led to a significant reduction in breast cancer cell migration and invasion than that in vehicle control cells, comparable to the effect induced by progesterone-alone.